These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29360666)

  • 1. Specific Donor HLA-DR Types Correlate With Altered Susceptibility to Development of Chronic Lung Allograft Dysfunction.
    Haynes LD; Julliard WA; Mezrich JD; Leverson G; Meyer KC; Burlingham WJ
    Transplantation; 2018 Jul; 102(7):1132-1138. PubMed ID: 29360666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte antigen-DR13 and DR15 are associated with short-term lung transplant outcomes.
    Gracon AS; Liang TW; Rothhaar K; Wu J; Wilkes DS
    J Surg Res; 2016 Jun; 203(1):82-90. PubMed ID: 27338538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope analysis of the collagen type V-specific T cell response in lung transplantation reveals an HLA-DRB1*15 bias in both recipient and donor.
    Keller MR; Haynes LD; Jankowska-Gan E; Sullivan JA; Agashe VV; Burlingham SR; Burlingham WJ
    PLoS One; 2013; 8(11):e79601. PubMed ID: 24265781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts.
    Saini D; Weber J; Ramachandran S; Phelan D; Tiriveedhi V; Liu M; Steward N; Aloush A; Hachem R; Trulock E; Meyers B; Patterson GA; Mohanakumar T
    J Heart Lung Transplant; 2011 Jun; 30(6):624-31. PubMed ID: 21414808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Donor-Recipient Human Leukocyte Antigen Matching on Bronchiolitis Obliterans-Free Survival Among Lung Transplant Recipients With Connective Tissue Diseases.
    Courtwright AM; Diamond JM; Sandorfi N; Goldberg HJ
    Clin Transplant; 2024 Aug; 38(8):e15426. PubMed ID: 39136242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antibodies to lung self-antigens (Kα1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: Single center experience.
    Rao U; Sharma M; Mohanakumar T; Ahn C; Gao A; Kaza V
    Transpl Immunol; 2019 Jun; 54():65-72. PubMed ID: 30794945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological link between primary graft dysfunction and chronic lung allograft rejection.
    Bharat A; Kuo E; Steward N; Aloush A; Hachem R; Trulock EP; Patterson GA; Meyers BF; Mohanakumar T
    Ann Thorac Surg; 2008 Jul; 86(1):189-95; discussion 196-7. PubMed ID: 18573422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
    Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
    Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor HLA-DR Drives the Development of De Novo Autoimmunity Following Lung and Heart Transplantation.
    Jankowska Gan E; Agashe VV; Lema DA; Zhou Y; Gonzalez Bosc L; Sullivan JA; Greenspan DS; Burlingham WJ
    Transplant Direct; 2020 Oct; 6(10):e607. PubMed ID: 33062840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection.
    Tiriveedhi V; Angaswamy N; Brand D; Weber J; Gelman AG; Hachem R; Trulock EP; Meyers B; Patterson G; Mohanakumar T
    Clin Exp Immunol; 2012 Jan; 167(1):158-68. PubMed ID: 22132895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection.
    Bharat A; Saini D; Steward N; Hachem R; Trulock EP; Patterson GA; Meyers BF; Mohanakumar T
    Ann Thorac Surg; 2010 Oct; 90(4):1094-101. PubMed ID: 20868794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
    Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
    Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of HLA-DR mismatch status on retransplant-free survival and bronchiolitis obliterans syndrome‒free survival among sensitized lung transplant recipients.
    Courtwright AM; Kamoun M; Kearns J; Diamond JM; Golberg HJ
    J Heart Lung Transplant; 2020 Dec; 39(12):1455-1462. PubMed ID: 33071182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection.
    Bharat A; Narayanan K; Street T; Fields RC; Steward N; Aloush A; Meyers B; Schuessler R; Trulock EP; Patterson GA; Mohanakumar T
    Transplantation; 2007 Jan; 83(2):150-8. PubMed ID: 17264811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline in Club Cell Secretory Proteins, Exosomes Induction and Immune Responses to Lung Self-antigens, Kα1 Tubulin and Collagen V, Leading to Chronic Rejection After Human Lung Transplantation.
    Itabashi Y; Ravichandran R; Bansal S; Bharat A; Hachem R; Bremner R; Smith M; Mohanakumar T
    Transplantation; 2021 Jun; 105(6):1337-1346. PubMed ID: 32890135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.
    Chalermskulrat W; Neuringer IP; Schmitz JL; Catellier DJ; Gurka MJ; Randell SH; Aris RM
    Chest; 2003 Jun; 123(6):1825-31. PubMed ID: 12796156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction.
    Kaza V; Zhu C; Terada LS; Wang L; Torres F; Bollineni S; Mohanka M; Banga A; Joerns J; Mohanakumar T; Li QZ
    Hum Immunol; 2021 Jan; 82(1):25-35. PubMed ID: 33129576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
    Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
    J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA Matching at the Eplet Level Protects Against Chronic Lung Allograft Dysfunction.
    Walton DC; Hiho SJ; Cantwell LS; Diviney MB; Wright ST; Snell GI; Paraskeva MA; Westall GP
    Am J Transplant; 2016 Sep; 16(9):2695-703. PubMed ID: 27002311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of current strategies for surveillance and management of donor-specific antibodies: Single-center study.
    Sullivan D; Ahn C; Gao A; Lacelle C; Torres F; Bollineni S; Banga A; Mullins J; Mohanka M; Ring S; Wait M; Peltz M; Duddupudi P; Surapaneni D; Kaza V
    Clin Transplant; 2018 Jul; 32(7):e13285. PubMed ID: 29774598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.